바로가기 메뉴
본문 바로가기
메뉴 바로가기
페이지 하단 바로가기

지속적인 수익 창출과 투명한 경영 항상 주주 가치 극대화를 위해 노력하겠습니다.

Financial Statements

ASSETS(Unit : ₩ one million)

Dongkoo Bio&Pharma ASSETS Financial Statements
Subject 2013 2012 2011
TOTAL ASSETS 72,440 73,666 62,259
Ⅰ. CURRENT ASSETS 35,525 33,016 34,968
(1) QUICK ASSETS 18,853 17,613 24,407
(2) INVENTORIES 16,672 15.403 10,561
Ⅱ. NONCURRENT ASSETS 36,915 40,649 27,291
(1) INVESTMENTS 4,513 6,006 2,047
(2) PROPERTY AND EQUIPMENT 30,342 30,146 21,718
(3) INTANGIBLE ASSETS 902 941 1,173
(4) OTHER ASSETS 1,158 3,557 2,354

LIABILITIES(Unit : ₩ one million)

Dongkoo Bio&Pharma 2013, 2012, 2011 LIABILITIES Financial Statements DATA
Subject 2013 2012 2011
TOTAL LIABILITIES 53,798 55,953 48,201
Ⅰ. CURRENT LIABILITIES 38,004 39,769 36,863
Ⅱ. LONG-TERM LIABILITIES 15,794 16,184 11,339

EQUITY(Unit : ₩ one million)

Dongkoo Bio&Pharma 2013, 2012, 2011 EQUITY Financial Statements DATA
Subject 2013 2012 2011
TOTAL EQUITY 18,642 17,712 14,057
Ⅰ. CAPITAL STOCK 3,471 3,171 2,701
Ⅱ. ADDITIONAL PAID-IN CAPITAL 8,363 5,587 4,149
Ⅲ. ACCUMULATED OTHER COMPREHENSIVE INCOME 5,806 8,104 8,447
Ⅳ. RETAINED EARNINGS 1,062 850 -1,241